M&A News: Biotech Group Zymeworks Buys Lung Disease-Fighting Peer Theravance for $1B
Source: news.google.com
Published: Jun 29, 2026 10:41
Source: news.google.com
Published: Jun 29, 2026 10:41
Related Stories
June 29, 2026: NIH Collaboratory Biostatistics Expert Fan Li Receives ASPPH and COPSS Awards Rethinking Clinical Trials
#Clinical TrialsWhy This Biotech Stock Is Falling After a $929 Million Buyout Lifeline Barron's
#Biotech HeadlinesMayo Clinic study finds common drug may help prevent life-threatening liver failure after surgery Florida Hospital News and Healthcare Report
#Clinical TrialsZymeworks to acquire troubled biotech Theravance in $929M deal Endpoints News
#Biotech HeadlinesNetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company GlobeNewswire
#Clinical TrialsNeurogene says Rett gene therapy drove 47 milestones in 10 patients Stock Titan
#Clinical TrialsAdd Shortcut
Open this site faster like an app from your phone home screen.